The first and only US-manufactured, FDA-approved RTU vasopressin with up to 12 months of room temperature stability1,2*

Available in two concentrations

20 units/100 mL (0.2 units/mL)
40 units/100 mL (0.4 units/mL)

*Product requires refrigeration between 2°C to 8°C (36°F to 46°F); do not freeze. Vials may be held up to 12 months upon removal from refrigeration to room temperature storage conditions between 20°C to 25°C (68°F to 77°F), anytime within the labeled shelf life.1,2
Vasostrict® product available in two concentrations

Not actual size.

Up to 12-month shelf life at room temperature1,2†

†Vials may be held up to 12 months upon removal from refrigeration to room temperature storage conditions between 20°C to 25°C (68°F to 77°F), anytime within the labeled shelf life.1,2

24-month total shelf life1‡

‡Product requires refrigeration between 2°C to 8°C (36°F to 46°F); do not freeze.1,2

Vasostrict® is a sterile, aqueous solution of synthetic arginine vasopressin for intravenous administration.2 Vasopressin is a polypeptide hormone. Vasostrict® is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines.

Vasostrict® Premixed Solution comes in ready-to-use, single-dose vials that do not require further dilution prior to administration.2

 May offer enhanced inventory management with 24-month total shelf life1§
 Preservative-free
 Available through your wholesaler
 Does not require compounding, diluting, mixing, or transferring, which may reduce waste3 and the risk of preparation error4
 Compatible with most automated dispensing machines
 Aligns with medication strategies of ASHP Guidelines on Preventing Medication Errors in Hospitals4
§Product requires refrigeration between 2°C to 8°C (36°F to 46°F); do not freeze.1,2

References: 1. Data on file. DOF-VS-02. Endo USA, Inc.; September 21, 2023. 2. Vasostrict®. Prescribing Information. Endo USA, Inc. 3. American Society of Health-System Pharmacists. ASHP guidelines on medication cost management strategies for hospitals and health systems. Am J Health-Syst Pharm. 2008;65:1368-1384. 4. American Society of Health-System Pharmacists. ASHP guidelines on preventing medication errors in hospitals. Am J Health-Syst Pharm. 2018;75(19):1493-1517.